Ignite Creation Date:
2024-05-06 @ 4:22 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04964934
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-04
First Post:
2021-06-30
Brief Title:
Phase III Study to Assess AZD9833 CDK46 Inhibitor in HRHER2-MBC With Detectable ESR1m Before Progression SERENA-6
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11-26
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-30
First Submit QC Date:
July 14 2021
Study First Post Date:
2021-07-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-25
Last Update Post Date:
2024-06-04
Last Update Post Date Type:
ACTUAL